The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers

References

• Talbäck M, Stenbeck M, Rosén M, Glimelius B. Cancer survival in Sweden. Acta Oncol 2003; 42: 637–59
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Marijnen CA, Colenbrander AC, Klein Kranenbarg E, Steup WH, van Krieken JH, et al. Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: A population-based study in the west Netherlands. Eur J Surg Oncol 1998; 24: 528–35
   PubMed Web of Science ®Google Scholar
• Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007; 14: 447–54
   PubMed Web of Science ®Google Scholar
• Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000; 356: 93–6
   PubMed Web of Science ®Google Scholar
• Dahlberg M, Glimelius B, Påhlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg 1999; 86: 379–84
   PubMed Web of Science ®Google Scholar
• Birgisson H, Talback M, Gunnarsson U, Pahlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005; 31: 845–53
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002; 89: 1142–9
   PubMed Web of Science ®Google Scholar
• Colorectal Cancer Collaborative Group. Adjuvant therapy for rectal cancer: A systematic overview of 8507 patients from 22 randomised trials. Lancet 2001;358:1291–304.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Grönberg H, Järhult J, Wallgren A, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003; 42: 476–92
   PubMed Web of Science ®Google Scholar
• Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg 2007; 94: 113–8
   PubMed Web of Science ®Google Scholar
• Birgisson H, Påhlman L, Gunnarsson U, Glimelius B. Late adverse effects of radiation therapy for rectal cancer–a systematic overview. Acta Oncol 2007; 46: 504–16
   PubMed Web of Science ®Google Scholar
• Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging–a meta-analysis. Radiology 2004; 232: 773–83
   PubMed Web of Science ®Google Scholar
• Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668–74
   PubMed Web of Science ®Google Scholar
• Blomqvist L, Holm T, Nyren S, Svanstrom R, Ulvskog Y, Iselius L. MR imaging and computed tomography in patients with rectal tumours clinically judged as locally advanced. Clin Radiol 2002; 57: 211–8
   PubMed Web of Science ®Google Scholar
• Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones R. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roentgenol 2007; 188: 442–51
   PubMed Web of Science ®Google Scholar
• Brown G, Daniels IR. Preoperative staging of rectal cancer: The MERCURY research project. Recent Results Cancer Res 2005; 165: 58–74
   PubMedGoogle Scholar
• MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY study. Radiology 2007;243:132–9.
   PubMed Web of Science ®Google Scholar
• Smith N, Brown G. Preoperative staging in rectal cancer. Acta Oncol 2008;47: 20–31.
   PubMed Web of Science ®Google Scholar
• Glimelius B. Rectal cancer irradiation. Long course, short course or something else?. Acta Oncol 2006; 45: 1013–7
   PubMed Web of Science ®Google Scholar
• Smith NJ , Barbachano Y , Norman AR, Swift RI , Abulafi AM . Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2007; (in press).
   Web of Science ®Google Scholar
• Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114–23
   PubMed Web of Science ®Google Scholar
• Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006; 24: 4620–5
   PubMed Web of Science ®Google Scholar
• Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M, et al. Long-term results of a randomised trial comparing preoperative short-course radiotherapy vs preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215–23
   PubMed Web of Science ®Google Scholar
• Sebag-Montefiore D, Steele R, Quirke P, Grieve R, et al, for the NCRI colorectal cancer study group and CR07. Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. J Clin Oncol 2006; Proc ASCO;24:Abstr 3511.
   PubMed Web of Science ®Google Scholar
• Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731–40
   PubMed Web of Science ®Google Scholar
• Braendengen M, Tveit KM, Berglund Å, Birkemeyer E, Frykholm G, Påhlman L, et al.A randomized phase III study (LARCS) comparing preoperative radiotherapy alone versus chemoradiotherapy in non-resectable rectal cancer. Eur J Cancer 2005; ECCO 13. Abstr 612.
   Google Scholar
• Frykholm GJ, Pahlman L, Glimelius B. Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001; 50: 427–34
   PubMed Web of Science ®Google Scholar
• Pfeiffer P. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: A phase I trial. Acta Oncol 2005; 44: 224–9
   PubMed Web of Science ®Google Scholar
• Glimelius B. Chemoradiotherapy for rectal cancer–is there an optimal combination?. Ann Oncol 2001; 12: 1039–45
   PubMed Web of Science ®Google Scholar
• Courdi A. Fractionation sensitivity and equivalent doses. Commenting the Editorial by Glimelius. Acta Oncol 2007;46:395–6; author reply 396.
   PubMed Web of Science ®Google Scholar
• Suwinski R, Wzietek I, Tarnawski R, Namysl-Kaletka A, Kryj M, Chmielarz A, et al. Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2007; 69: 793–9
   PubMed Web of Science ®Google Scholar